Oppenheimer Brokers Lower Earnings Estimates for Addus HomeCare Co. (NASDAQ:ADUS)

Addus HomeCare Co. (NASDAQ:ADUS – Get Rating) – Research analysts at Oppenheimer reduced their Q4 2022 earnings per share estimates for shares of Addus HomeCare in a report released on Thursday, January 19th. Oppenheimer analyst M. Wiederhorn now anticipates that the company will post earnings of $0.84 per share for the quarter, down from their previous forecast of $0.87. The consensus estimate for Addus HomeCare’s current full-year earnings is $3.12 per share. Oppenheimer also issued estimates for Addus HomeCare’s FY2023 earnings at $3.50 EPS.

Addus HomeCare (NASDAQ:ADUS – Get Rating) last issued its earnings results on Monday, October 31st. The company reported $0.80 earnings per share for the quarter, missing the consensus estimate of $0.81 by ($0.01). The company had revenue of $240.50 million for the quarter, compared to analyst estimates of $242.21 million. Addus HomeCare had a return on equity of 8.46% and a net margin of 4.77%. The company’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.80 earnings per share.

ADUS has been the topic of several other reports. Royal Bank of Canada boosted their target price on Addus HomeCare from $110.00 to $121.00 and gave the stock an “outperform” rating in a report on Wednesday, November 2nd. StockNews.com lowered shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, January 14th. Six research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $112.60.

Addus HomeCare Trading Up 2.4 %

Shares of Addus HomeCare stock opened at $109.58 on Friday. The stock has a market cap of $1.77 billion, a P/E ratio of 39.85, a P/E/G ratio of 2.64 and a beta of 0.82. The stock’s 50 day simple moving average is $104.47 and its 200-day simple moving average is $98.79. Addus HomeCare has a 1-year low of $68.57 and a 1-year high of $112.89. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.87 and a quick ratio of 1.87.

Insider Activity

In other news, COO W Bradley Bickham sold 7,500 shares of Addus HomeCare stock in a transaction that occurred on Tuesday, November 22nd. The shares were sold at an average price of $105.21, for a total transaction of $789,075.00. Following the sale, the chief operating officer now owns 39,284 shares of the company’s stock, valued at approximately $4,133,069.64. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other Addus HomeCare news, COO W Bradley Bickham sold 7,500 shares of the company’s stock in a transaction on Tuesday, November 22nd. The stock was sold at an average price of $105.21, for a total transaction of $789,075.00. Following the transaction, the chief operating officer now directly owns 39,284 shares in the company, valued at $4,133,069.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO R Dirk Allison sold 700 shares of the company’s stock in a transaction on Thursday, November 3rd. The stock was sold at an average price of $108.00, for a total value of $75,600.00. Following the transaction, the chief executive officer now owns 80,554 shares in the company, valued at $8,699,832. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 32,714 shares of company stock valued at $3,524,933. 4.50% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Addus HomeCare

Several hedge funds have recently bought and sold shares of the company. BlackRock Inc. lifted its stake in Addus HomeCare by 1.4% during the 1st quarter. BlackRock Inc. now owns 2,664,889 shares of the company’s stock worth $248,608,000 after acquiring an additional 37,830 shares in the last quarter. Vanguard Group Inc. lifted its stake in Addus HomeCare by 1.1% during the 3rd quarter. Vanguard Group Inc. now owns 1,115,872 shares of the company’s stock worth $106,276,000 after acquiring an additional 12,363 shares in the last quarter. Eaton Vance Management lifted its stake in Addus HomeCare by 1.6% during the 3rd quarter. Eaton Vance Management now owns 757,813 shares of the company’s stock worth $72,175,000 after acquiring an additional 12,046 shares in the last quarter. Principal Financial Group Inc. lifted its stake in Addus HomeCare by 17.7% during the 2nd quarter. Principal Financial Group Inc. now owns 605,038 shares of the company’s stock worth $50,387,000 after acquiring an additional 90,927 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in Addus HomeCare by 2.7% during the 3rd quarter. Dimensional Fund Advisors LP now owns 590,980 shares of the company’s stock worth $56,285,000 after acquiring an additional 15,340 shares in the last quarter. Institutional investors and hedge funds own 97.42% of the company’s stock.

About Addus HomeCare

(Get Rating)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health.